4//SEC Filing
CAUSEY CHRISTOPHER 4
Accession 0001237334-26-000001
CIK 0001082554other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:59 PM ET
Size
9.0 KB
Accession
0001237334-26-000001
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$119.76/sh+1,000$119,760→ 5,190 total - Sale
Common Stock
2026-01-02$500.01/sh−1,000$500,015→ 4,190 total - Exercise/Conversion
Stock Option
2026-01-02−1,000→ 8,320 totalExercise: $119.76From: 2021-06-26Exp: 2030-06-26→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $500.00 to $500.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001237334
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:59 PM ET
- Size
- 9.0 KB